bloodwork
LOINC parts

72,372 parts · page 476 of 1,448 · all codes

PartNameTypeTests
LP212124-4 Perineal pad count COMPONENT 1
LP212125-1 Referring physician phone number COMPONENT 1
LP212126-9 Hydration status COMPONENT 1
LP212127-7 Preoperative measures for patient safety panel COMPONENT 1
LP212129-3 Chromosome 17p13.1 deletion and 14q32 rearrangements COMPONENT 1
LP212130-1 Interleukin 17A COMPONENT 1
LP212131-9 SPECT+CT METHOD 6
LP212132-7 Views for thyroid tumor COMPONENT
LP212133-5 Extremity - unilateral SYSTEM
LP212134-3 Extremity veins - unilateral SYSTEM 2
LP212137-6 Send document that conforms to C-CDA R1.1 template COMPONENT 1
LP212138-4 Send document that conforms to C-CDA R2.1 template COMPONENT 1
LP212139-2 Send document that conforms to CDP Set 1 R1.0 template COMPONENT 1
LP212140-0 Send document that conforms to CDP Set 1 R1.1 template COMPONENT 1
LP212141-8 Document template attachment request modifier codes COMPONENT 1
LP212142-6 Scope.modifier.document template PROPERTY 10
LP212144-2 Views for transplanted kidney COMPONENT
LP212145-9 Ureter and Urinary bladder SYSTEM 1
LP212146-7 MYD88 gene p.Leu265Pro COMPONENT
LP212147-5 MYD88 gene COMPONENT
LP212148-3 Views for glomerular filtration rate COMPONENT
LP212149-1 Tobacco smoking status for tobacco smoker COMPONENT 1
LP212150-9 Influenza virus types A and B and subtypes RNA panel COMPONENT 2
LP212152-5 Clostridium botulinum toxin C botC gene COMPONENT 1
LP212153-3 Clostridium botulinum toxin D botD gene COMPONENT 1
LP212154-1 Clostridium botulinum toxin E botE gene COMPONENT 1
LP212155-8 Clostridium botulinum toxin F botF gene COMPONENT 1
LP212156-6 Clostridium botulinum toxin G botG gene COMPONENT 1
LP212157-4 Chromosome region 6q22 rearrangements COMPONENT 1
LP212158-2 Chromosome region Yp11.3 deletion AndOr rearrangement COMPONENT 1
LP212160-8 Chromosome region 1q21 COMPONENT
LP212161-6 Respiratory pathogens DNA and RNA COMPONENT 6
LP212162-4 Chromosome region 13q14 COMPONENT
LP212163-2 Chromosome region 17p13.1 COMPONENT
LP212164-0 Phytanate and pristanate panel COMPONENT 1
LP212165-7 Docosatrienoate (C22:3w9) COMPONENT 2
LP212166-5 Eicosatrienoate (C20:3w3) COMPONENT 2
LP212168-1 3-Hydroxyoctanoylcarnitine (C8-OH) COMPONENT
LP212171-5 Fever duration COMPONENT 2
LP212174-9 Rash duration COMPONENT 2
LP212175-6 Date of fever onset COMPONENT 2
LP212176-4 Maximum body temperature COMPONENT 2
LP212177-2 Ureidopropionate COMPONENT
LP212178-0 Chemokine (C-C motif) ligand 17 COMPONENT 1
LP212179-8 Laboratory communication about newborn screening COMPONENT 1
LP212184-8 Setting of exposure to illness COMPONENT 1
LP212185-5 SAP and XIAP COMPONENT 1
LP212186-3 Varicella zoster virus surveillance panel COMPONENT 1
LP212188-9 Sukharev method METHOD 1
LP212193-9 Methotrexate monoglutamate COMPONENT 1

← prev · next →